Global NIPT Market to exceed USD 2.5 Bn by 2025 Led by US, China - Reuters

 

Global NIPT Market to exceed USD 2.5 Bn by 2025 Led by US, China

Global NIPT Market to exceed USD 2.5 Bn by 2025 Led by US, China

Tue Jul 3, 2018 - 06:45am UTC

MarketStudyReport.com adds Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025, NIPT research report to the pharmaceuticals and healthcare collection of its store.

Selbyville, United States – July 3, 2018

Global Non-Invasive Prenatal Testing (NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025, according to this new research report. United States is anticipated to be the most attractive market in the worldwide NIPT market. China NIPT test industry is set to cross USD 400 Million by 2025, with two child policy likely to boost overall Chinese non invasive prenatal testing market. Panorama test accounted for the highest share in NIPT market while Verifi test has the second highest revenue share. Rising focus on reimbursement for NIPT test will revolutionize the market.

The non-invasive prenatal testing market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods. This report contains a granular analysis of the present industry situations, NIPT market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of NIPT tests and Countries-based market. The report also includes assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.

Order a copy of this premium report on NIPT industry at https://www.marketstudyreport.com/securecheckout/paymenta/1162034?msfpaycode=sumsf .

The major companies dominating the non invasive prenatal testing market for products, services and continuous product developments are: Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health and NIPD Genetics. Major and promising non-invasive prenatal testing (nipt) covered under this report are: Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests.

Country level NIPT market information is provided in this research for United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries. The Latest Industry Data Included in this Report:

• Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)
• Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)
• NIPT Market Share Analysis, by Test, 2014 – 2025 (%)
• NIPT Market Share Analysis, by Major Countries, 2014 – 2025 (%)
• Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025
• Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025
• Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test
• Major Deals in Global Non–Invasive Prenatal Testing Market
• Global Perspectives on Clinical Adoption of NIPT
• Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors
• Key Companies Analysis

Before making a purchase decision, request and evaluate a sample of this premium NIPT market report: https://www.marketstudyreport.com/request-a-sample/1162034/ .

Another report titled “2018 Global Non-Invasive Prenatal Testing (NIPT) Industry Report – History, Present and Future” is of 148 pages and covers 3 key segments – geography, end use / application and competitor segment. For competitor segment, the report includes global key players of Non-Invasive Prenatal Testing (NIPT) market as well as some small players. The companies include: Quest Diagnostics, Roche, Illumina, Sequenom, Natera, LabCorp et al. The information for each competitor includes: Company Profile, Main Business Information, SWOT Analysis, Sales, Revenue, Price and Gross Margin as well as Market Share. Read more at
https://www.marketstudyreport.com/reports/2018-global-non-invasive-prenatal-testing-nipt-industry-report-history-present-and-future .

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog

Contact Info:
Name: Arun Hegde
Email: sales@marketstudyreport.com
Organization: Market Study Report

This content is produced independently of Reuters Editorial News. For content inquiry, please contact reuters@vcnewsnetwork.com

For content enquiry, please reach us at

Latest News >

Japan’s Taisho to increase stakes ownership in Vietnam-listed DHG Pharma to 32 percent

This will cement the Japanese pharmaceutical company’s position as the 2nd major shareholder in DHG Pharma.

09:44am UTC

Singapore’s Anchanto raises US$4 million from MDI Ventures in ongoing Series C round

The SaaS technology company will use the funds to expand market outreach and establish a stronger presence in Southeast Asia.

05:12am UTC

Online parenting platform Babytree applies to list on Hong Kong Stock Exchange

Babytree will use the IPO proceeds to fund expansion projects, research & development, as well as future investments including acquisition and strategic alliance.

07:54am UTC

Singapore’s food court operator Koufu plans US$62.3 million on SGX Mainboard

Koufu plans to start trading on July 18th and use the proceeds to fund integrated facility, revamps, and growth.

07:48am UTC

Singapore’s Digital Lender AsiaKredit to secure funding from SIG Asia

The investment will be used to fund loan capital as well as to enhance its proprietary technology platform, underwriting and the development of new products.

08:38am UTC